Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanomaShelly Kalaora, Yardena Samuels, Polina Greenberg et al.|Nature Communications|2020Cited by 156
CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanomaMichal Alon, Yardena Samuels|Oncotarget|2018Cited by 15